distributive shock; vasodilatory shock (multiple organ dysfunction syndrome)

From Aaushi
Jump to navigation Jump to search

Introduction

Failure to maintain adequate perfusion of vital organs secondary to, in part, decreased peripheral vascular resistance & loss of capillary integrity with transudation of intravascular fluid.

Etiology

Pathology

Clinical manifestations

Laboratory

Management

More general terms

More specific terms

Additional terms

References

  1. Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 136
  2. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 853-55
  3. 3.0 3.1 Journal Watch 22(18):139, 2002 Annane D et al JAMA 288:862, 2002 Abrahams E & Evans T, JAMA 288:886, 2002
  4. 4.0 4.1 Annane D et al, Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome Crit Care Med 2006; 34:22 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16374152
  5. 5.0 5.1 5.2 Medical Knowledge Self Assessment Program (MKSAP) 14, 18. American College of Physicians, Philadelphia 2006, 2018.
  6. 6.0 6.1 Khanna A, English SW, Wang XS et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 2017 Aug 3; 377:419. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28528561
  7. 7.0 7.1 7.2 7.3 Sinert RH Fast Five Quiz: Refresh Your Knowledge on Key Aspects of Sepsis. Medscape - Jun 07, 2018. https://reference.medscape.com/viewarticle/897550
  8. 8.0 8.1 McIntyre WF, Um KJ, Alhazzani W et al Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis. JAMA. 2018 May 8;319(18):1889-1900. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29801010